By Staff Writer, Global AgInvesting Media

The Agritech sector is famously resilient, but even by its own high standards, the latest funding data reveals a market that is aggressively recalibrating. For agribusiness leaders and tech developers, the New Market Pitch AgriTech market report offers a fascinating look at where the smart money is moving: away from broad-spectrum chemical reliance and toward high-precision, autonomous, and biological solutions.

The report is compiled by the New Market Pitch Team in an effort to track funding rounds, M&A, partnerships, product launches, policy changes and more. The end goal is to show those in the space a clear “market pitch,” demonstrating where opportunities for investment lie. Their database is designed to give fast, accurate information, with every data point checked, sourced and contextualized.

Here is a closer look at the AgriTech market report, following deals from Q1 2025 through Q1 2026.

The Quick Facts

Some of the key highlights from the report include:

• The AgriTech market saw 22 equity raises above $500k in the timeframe studied; that totaled around $337 million across five quarters
• Q1 2026 stood out as the most active quarter by deal count, however had had the lowest capital raised at $69 million
• The average deal size dropped from $45.1 million in Q2 2025 to $6.3 million in Q1 2026
• Europe generated the most deal flow in Q1 2026, with New Zealand and Australia producing the largest single-checks outside the U.S.
• Corteva Catalyst appeared as lead investor in two separate AgriTech rounds, Puna Bio and Resurrect Bio, making it a visible strategic investor
• Per the report, “The top deal in each quarter captured between 17% and 89% of that quarter’s total capital, showing how a single breakout company can completely reshape the quarterly funding picture in the AgriTech market.”
• For the first time in Q4 2025, animal genetics and reproductive biotech entered the New Market Pitch dataset

The $15.3 Million Average

If you look at the raw numbers from early 2025 through the first quarter of 2026, the average deal size sat comfortably at $15.3 million. However, that figure is a bit of a “statistical chameleon.” While 2025 featured fewer, larger “mega-deals”—like Halter’s $100 million Series D raise for virtual fencing—Q1 2026 saw a surge in volume with 11 distinct deals.“If you exclude the top deal in each quarter, the remaining AgriTech rounds cluster consistently between $5 million and $20 million, suggesting the underlying deal-size trend is stable and that the wide quarterly swings are outlier-driven rather than structural,” the report noted.

Automation: Not Just Drivers, But Decisions

Several deals centered around technologies focused on automation, from autonomous tractors to physical-AI machinery. Of note:

• Bonsai Robotics ($15M): Focuses on vision-based systems specifically for orchard machinery
• Agreenculture ($7M): Offers retrofit kits that turn existing fleets into autonomous machines
• Upside Robotics ($7.5M): Uses lightweight bots for precision fertilizer placement directly in the root zone

Retrofittable, specialized automation is showing its mettle and solving specific labor or efficiency gaps, with the hope of bypassing the expensive, all-in-one replacements.

Climate Resilience and Genomics 

Seed tech and genomics were two converging areas of note in the report. Companies like Singrow ($4.5M) and Biographica (~$8.7M) are using genomics in combination with seedling production to combat climate risk and disease resistance in seed companies.

In the past, developing a drought-resistant variety could take years; now, these platforms are aiming to slash those timelines, with Biographica even bringing AI into the mix to help discover positive resilience traits within seed varieties.

The Biological Boom: Targeted and Sustainable

If 2024 was the year of “biostimulants,” 2026 is the year of “precision biologicals.” The report noted several significant raises in this space:

• Vestaron ($20M+): Focusing on peptide-based bioinsecticides
• SenseUP (~$3.5M): Using RNAi biopesticides for highly targeted pest control
• Puna Bio ($20.3M): Leveraging “extremophile” microbes to boost nutrient uptake in harsh conditions

Puna Bio’s funds are aimed to help expand internationally, and, as the report noted, “with Corteva Catalyst leading a round that also drew in the Gates Foundation, signaling confidence in extremophile-derived biologicals for climate-stressed farming environments.”

Livestock Tech: Virtual Fences and IVF

While crop tech often steals the headlines, the livestock sector had some of the largest raises in the report. Halter ($100M) and NoFence ($35M) are proving that virtual fencing is no longer a gimmick—it’s a massive infrastructure play. By removing the need for physical fences, these technologies allow for “precision grazing,” which has direct benefits for soil health and carbon sequestration.Additionally, Nbryo’s $10M raise for bovine IVF suggests that the same genomic acceleration we see in crops is now being applied to cattle genetics, aiming to make elite traits accessible to commercial herds, and not just elite breeders.

The Bottom Line for Agribusiness

The “New Market Pitch” report paints a picture of an industry dedicated to the benefits of AgriTech. From lowering barriers by creating retrofitting kits and pulling together distributor partnerships (like RootWave/Garford) to having regulator alignment with almost every major raise designed to thrive in a world with stricter chemical regulations, these investments and innovations are making tech easier to adopt.

It appears the “alternative” technologies of five years ago are becoming a commercial standard of today. Whether you are an investor, a grower, or a tech provider, the current funding landscape suggests that the most successful players will be those who embrace the “integrated” farm—where biology, electricity, and autonomy work in tandem.

The content put forth by Global AgInvesting News and its parent company Arc Network LLC is intended to be used and must be used for informational purposes only. All information or other material herein is not to be construed as legal, tax, investment, financial, or other advice. Global AgInvesting and Arc Network LLC are not a fiduciary in any manner, and the reader assumes the sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this site.